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Calcium (Ca2+) released from the sarcoplasmic reticulum (SR) is crucial
for excitation–contraction (E–C) coupling. Mitochondria, the major
source of energy, in the form of ATP, required for cardiac contractility,
are closely interconnected with the SR, and Ca2+ is essential for opti-
mal function of these organelles. However, Ca2+ accumulation can
impair mitochondrial function, leading to reduced ATP production
and increased release of reactive oxygen species (ROS). Oxidative
stress contributes to heart failure (HF), but whether mitochondrial
Ca2+ plays a mechanistic role in HF remains unresolved. Here, we
show for the first time, to our knowledge, that diastolic SR Ca2+
leak causes mitochondrial Ca2+ overload and dysfunction in a murine
model of postmyocardial infarction HF. There are two forms of Ca2+
release channels on cardiac SR: type 2 ryanodine receptors (RyR2s)
and type 2 inositol 1,4,5-trisphosphate receptors (IP3R2s). Using mu-
rine models harboring RyR2 mutations that either cause or inhibit SR
Ca2+ leak, we found that leaky RyR2 channels result in mitochondrial
Ca2+ overload, dysmorphology, and malfunction. In contrast, cardiac-
specific deletion of IP3R2 had nomajor effect on mitochondrial fitness
in HF. Moreover, genetic enhancement of mitochondrial antioxidant
activity improved mitochondrial function and reduced posttransla-
tional modifications of RyR2 macromolecular complex. Our data dem-
onstrate that leaky RyR2, but not IP3R2, channels cause mitochondrial
Ca2+ overload and dysfunction in HF.
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Type 2 ryanodine receptor/Ca2+ release channel (RyR2) andtype 2 inositol 1,4,5-trisphosphate receptor (IP3R2) are the
major intracellular Ca2+ release channels in the heart (1–3).
RyR2 is essential for cardiac excitation–contraction (E–C) cou-
pling (2), whereas the role of IP3R2 in cardiomyocytes is less
well understood (3). E–C coupling requires energy in the form of
ATP produced primarily by oxidative phosphorylation in mito-
chondria (4–8).
Both increased and reduced mitochondrial Ca2+ levels have been
implicated in mitochondrial dysfunction and increased reactive ox-
ygen species (ROS) production in heart failure (HF) (6, 7, 9–17).
Albeit Ca2+ is required for activation of key enzymes (i.e., pyruvate
dehydrogenase phosphatase, isocitrate dehydrogenase, and
α-ketoglutarate dehydrogenase) in the tricarboxylic acid (also
known as Krebs) cycle (18, 19), excessive mitochondrial Ca2+
uptake has been associated with cellular dysfunction (14, 20).
Furthermore, the exact source of mitochondrial Ca2+ has not
been clearly established. Given the intimate anatomical and
functional association between the sarcoplasmic reticulum (SR)
and mitochondria (6, 21, 22), we hypothesized that SR Ca2+
release via RyR2 and/or IP3R2 channels in cardiomyocytes
could lead to mitochondrial Ca2+ accumulation and dysfunc-
tion contributing to oxidative overload and energy depletion.
Results and Discussion
Increased Mitochondrial Ca2+ in Failing Hearts. Cardiac mitochon-
drial Ca2+ (Fig. 1 A–D and Fig. S1) and ROS (Fig. 1E) were sig-
nificantly elevated in mice following myocardial infarction (MI).
To determine whether the observed mitochondrial Ca2+ overload
in failing hearts can be caused by SR Ca2+ leak via RyR2, we used a
murine model harboring a mutation that renders the channels leaky
(RyR2-S2808D) and a second model (RyR2-S2808A) with RyR2
channels protected against leak. Ca2+ sparks frequency (diastolic
openings of RyR2 channels that reflect SR Ca2+ leak) was signifi-
cantly increased (Fig. S2A), and SR Ca2+ load reduced (Fig. S2B) in
cardiomyocytes from RyR2-S2808D mice compared with WT and
RyR2-S2808A cardiomyocytes.
Notably, RyR2-mediated SR Ca2+ leak (Fig. S2) was associated
with increased mitochondrial Ca2+ (Fig. 1 A and D) and ROS
production (Fig. 1E). Constitutive cardiac SR Ca2+ leak via RyR2
(RyR2-S2808D mice) resulted in dysmorphic and malfunctioning
mitochondria (Fig. S3). We observed a marked reduction in mito-
chondrial size (Fig. S3D), aspect ratio (Fig. S3G), and form factor
(Fig. S3H) in left ventricular cardiomyocytes harboring leaky RyR2
channels, reflecting a low fusion-to-fission ratio. These data indicate
that intracellular Ca2+ leak via RyR2 correlates with augmented
mitochondrial fragmentation, strongly supporting a functional role
for Ca2+ in regulating mitochondrial morphological dynamism.
Importantly, our data showing increased cardiac mitochon-
drial Ca2+ in HF, determined in absolute values in isolated or-
ganelles (Fig. 1A) and confirmed in dynamic evaluations at the
cellular level (Fig. 1 B–D and Fig. S1), reconcile conflicting re-
ports concerning mitochondrial Ca2+ in failing hearts (7, 10, 12,
13, 15, 17).
Significance
We demonstrate that intracellular Ca2+ leak causes mitochon-
drial Ca2+ overload and dysfunction in postischemic heart failure
(HF). In particular, sarcoplasmic reticulum (SR) Ca2+ leak via type
2 ryanodine receptor (RyR2)—but not type 2 inositol 1,4,5-
trisphosphate receptor (IP3R2)—channels plays a fundamental
role in the pathophysiology of mitochondrial Ca2+ overload and
dysfunction in HF. We present here a previously undisclosed
molecular mechanism in HF with crucial implications in cardiac
physiology. Indeed, our data establish a feedback loop between
SR and mitochondria in which SR Ca2+ leak triggers mitochon-
drial dysfunction and increases the production of free radicals,
which in turn lead to posttranslational modifications of RyR2
and enhance intracellular Ca2+ leak, thereby contributing to
impaired cardiac function after myocardial infarction.
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Effects of Redox Imbalance on RyR2 Channel in Postischemic HF. We
have previously shown that protein kinase A (PKA) phosphoryla-
tion and oxidation of RyR2 channels cause SR Ca2+ leak and
contribute to HF progression (1, 2). HF-related PKA phosphory-
lation—in part also attributable to decreased cAMP type 4 phos-
phodiesterase, PDE4D3, in the RyR2 channel complex (23)—
nitrosylation, and oxidation of RyR2 were attenuated in a mouse
model (mCAT) with decreased ROS levels obtained via targeted
overexpression of human catalase in mitochondria (Fig. 2 A–D).
Reduced binding of the RyR2 stabilizing subunit calstabin2 (24)
to the channel due to RyR2 oxidation and PKA phosphorylation
causes spontaneous diastolic SR Ca2+ release contributing to car-
diac dysfunction in HF (1, 2). Genetically reducing RyR2 oxidation
(mCAT mice) or preventing RyR2 PKA phosphorylation (RyR2-
S2808A mice harboring RyR2 channels that cannot be PKA-
phosphorylated) improved calstabin2 and PDE4D3 binding to
RyR2 (Fig. 2 A–F) and cardiac performance (Fig. 2G and Table S1)
after MI. Mitochondrial morphology (Fig. 3 A–I and Fig. S4)
and function (Fig. 3 J–M and Table S2) were also improved in
mCAT mice.
Oxidative overload in cardiomyocytes originates from multiple
sources, including mitochondria, NAD(P)H oxidase, xanthine
oxidase, and uncoupled nitric oxide synthase (16, 25, 26).
Mitochondrial-derived ROS are elevated during cardiac over-
load or ischemic stress (4, 26, 27). Mitochondrial membrane
potential, Δψm, is closely linked to Ca2+ levels and to mito-
chondrial ROS production; indeed, depolarized mitochondria
produce more ROS, leading to further organelle depolarization,
resulting in a vicious cycle. The decrease in Δψm observed in
mitochondria from RyR2-S2808D ventricular cardiomyocytes
(Fig. S3J) is consistent with a progressive decline in Δψm due
to increasing [Ca2+] in cardiac mitochondria and is most likely
due to elevated cytosolic [Ca2+] caused by RyR2-mediated SR
Ca2+ leak (10). Supporting this view, mitochondria exposed to
elevated [Ca2+] exhibit reduced Δψm, due to the large mito-
chondrial Ca2+ current generated during local [Ca2+] transients (28).
Ventricular cardiomyocytes harboring constitutively leaky
RyR2 channels exhibited a reduction in mitochondrial ATP
content and generation (Fig. S3 L and M), consistent with
previous observations in failing human hearts (6). Further
studies are needed to investigate in detail other systems, in-
cluding neurohormonal and (epi)genetic mechanisms, endoplas-
mic reticulum (ER) stress, necrosis/apoptosis, and autophagy, that
might participate in the regulation of bioenergetic homeostasis in
HF (5, 6, 19, 25, 29).
Distinctive Roles of RyR2 and IP3R2 in the Pathophysiology of
Mitochondrial Dysfunction in HF. To determine the source of SR
Ca2+ leak that causes mitochondrial overload in failing hearts,
we investigated the roles of the two major Ca2+ release channels
on myocardial SR: RyR2 and IP3R2 (1).
We generated a murine model (IP3R2CVKO) in which IP3R2
expression was specifically ablated in ventricular cardiomyocytes
via Cre/Lox recombination (Fig. S5 A–E). IP3R2CVKO mice sur-
vived to adulthood without alterations in baseline myocardial
function, and there was no up-regulation of the other two isoforms
of IP3R (IP3R1 and IP3R3) (Fig. S5 F and G). Ca2+ sparks, SR
Ca2+ load (Fig. S6), mitochondrial Ca2+ level (Fig. S6C and Fig.
S7 A and B), and ROS production (Fig. S6D) were not signifi-
cantly changed in IP3R2CVKO ventricular cardiomyocytes evalu-
ated both in sham or post-MI mice. Myocardial mitochondria
from IP3R2CVKO mice were normal (Fig. 4), and there was no
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Fig. 1. Increased mitochondrial Ca2+ in post-MI heart failure. (A) Direct measurement of total Ca2+ content in mitochondria isolated from sham or failing
ventricular samples of 6-mo-old WT, RyR2-S2808A, RyR2-S2808D, mCAT, and mCAT × RyR2-S2808D mice. Mitochondria were purified from ≥6 mice in each
experimental group. (B–D) Mitochondrial Ca2+ dynamics in response to 3 Hz in cardiomyocytes (n = 22–35) enzymatically isolated from at least 7 mice per
group isolated from the indicated groups. (E) Mitochondrial ROS generation in ventricular cardiomyocytes isolated from the indicated mice using the mi-
tochondria-targeted fluorescent indicator of superoxide production MitoSOX Red; n > 120 ventricular myocytes from ≥4 mice in each group. Data shown
represent mean ± SEM from triplicate experiments. *P < 0.05 vs. WT; #P < 0.05 vs. RyR2-S2808D, ANOVA, Tukey–Kramer post hoc test; !P < 0.05 vs. SHAM, two-
tailed t test. AU, arbitrary units; ROS, reactive oxygen species.
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major effect on acute HF progression (Fig. S7C and Table S1).
Further investigations are warranted to explore the potential role
of IP3R2 in ischemia/reperfusion and in long-term ischemic HF,
especially given the reported involvement of IP3R2 in advanced
stages of HF (30).
Prevention of RyR2 Posttranslational Modifications Attenuates
Mitochondrial Dysfunction in HF. Mitochondrial ROS levels were
markedly reduced in cardiomyocytes isolated from mCAT × RyR2-
S2808D mice [mice expressing leaky RyR2 channels (RyR2-S2808D)
crossed with mCAT mice] compared with RyR2-S2808D littermates,
both in HF and sham conditions (Fig. 1E). Moreover, RyR2 oxidation
and nitrosylation were significantly decreased in left ventricular sam-
ples from mCAT × RyR2-S2808D mice compared with RyR2-
S2808D littermates (Fig. 2 A–C). SR Ca2+ leak (Fig. S2) and mito-
chondrial Ca2+ accumulation (Fig. 1 A–D and Fig. S1) observed
in RyR2-S2808D were significantly reduced after crossing with
mCAT mice. Additionally, post-MI, HF progression was mark-
edly attenuated in mCAT × RyR2-S2808D mice (Fig. 2G and
Table S1). These data show that mitochondria are a critical
source of ROS that oxidizes RyR2 and promotes SR Ca2+ leak in
failing hearts although there are likely additional sources of
ROS, such as xanthine oxidase, that are significantly increased in
failing hearts (Fig. S8).
Genetic ablation of the RyR2 PKA phosphorylation site at
Ser2808 attenuated cardiac mitochondrial dysmorphology after MI
(Fig. 3 B and F–I) and reduced mitochondrial ROS levels (Fig. 1E),
indicating that, in addition to oxidation, PKA phosphorylation
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Fig. 2. Posttranslational modifications of RyR2 complex and HF progression post-MI. (A) Biochemical evaluation of RyR2 macromolecular complex in left
ventricular samples from sham and heart failure (HF) mice. To determine channel oxidation, the carbonyl groups in the protein side chains of immuno-
precipitated RyR2 were derivatized to 2,4 dinitrophenylhydrazone (2,4 DNPH) by reaction with 2,4 dinitrophenylhydrazine. The 2,4 DNPH signal associated
with RyR2 was determined by anti-DNP antibody (specificity for RyR2 was achieved due to immunoprecipitation of the protein). Anti-Cys NO antibody analysis
of immunoprecipitated RyR2 was used to measure RyR2 nitrosylation. Quantification of RyR2 oxidation (B), Cys-nitrosylation (C), phosphorylation at Ser2808
(D), PDE4D3 (E), and calstabin2 (F) bound to RyR2; note that constitutive phosphorylation of Ser2808, mimicked by the aspartate residue substitution in RyR2-
S2808D mice, cannot be detected. Data shown represent mean ± SEM from triplicate experiments. *P < 0.05 vs. WT; #P < 0.05 vs. RyR2-S2808D, ANOVA,
Tukey–Kramer post hoc test; !P < 0.05 vs. SHAM, two-tailed t test. (G) Progressive cardiac dysfunction after myocardial infarction (MI) assessed by serial
echocardiographic analyses. LVEF, left ventricular ejection fraction. Data are shown as mean ± SEM; *P < 0.05 vs. WT; #P < 0.05 vs. RyR2-S2808D; ANOVA
repeated measures; n = 16–20 per group. AU, arbitrary units. See also Table S1.
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of RyR2 channel promotes SR Ca2+ leak and mitochondrial
dysfunction. Indeed, RyR2-S2808A ventricular cardiomyocytes
exhibited reduced mitochondrial Ca2+ uptake (Fig. 1 B–D and
Fig. S1) and increased mtDNA levels (Fig. 3K). We also ob-
served a trend toward ameliorated Δψm dissipation (Fig. 3J)
and increased ATP content and synthesis (Fig. 3 L and M).
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Fig. 3. Leaky RyR2 channels and mitochondrial dysfunction in heart failure. (A–E) Representative transmission electron micrographs of cardiac mitochondria post
myocardial infarction fromWT (A), RyR2-S2808A (no leak) (B), RyR2-S2808D (leaky) (C), mCAT (D), mCAT × RyR2-S2808D (E), n = 5 per group. (Magnification: A–E,
15,000×; Insets, 50,000×.) (Scale bars: 500 nm.) Note the diffuse myofibrillar disarray. (F–I) Quantification of ultrastructural mitochondrial alterations depicted in
A–E. Mitochondrial size (F) and cristae density (G). Numbers in the bars indicate the number of mitochondria analyzed. Quantification of mitochondrial number
per image (H) and percentage of abnormal mitochondria per image at 15,000× (I). Relative number of damaged mitochondria was quantified by blinded ob-
servers from 8 to 10 images from different fields. Data are shown as mean ± SEM, *P < 0.05 vs. WT; #P < 0.05 vs. RyR2-S2808D, ANOVA, Tukey–Kramer post hoc
test. (J) Assessment of the inner mitochondrial membrane potential (Δψm); the arrow denotes addition of H2O2 (100 μM). FCCP, carbonylcyanide-p-trifluoro-
methoxy-phenyl-hydrazone. The * indicates significant difference (P < 0.05, ANOVA repeated measures, Tukey–Kramer post hoc test) of the WT group (n = 8)
compared with RyR2-S2808D (n = 7), mCAT × RyR2-S2808D (n = 7), and mCAT (n = 6), or between RyR2-S2808D and mCAT × RyR2-S2808D groups. (K) Mito-
chondrial DNA (mtDNA)/nuclear DNA (nDNA) copy number and (L) ATP content assessed in left ventricle (n = 8 per group). (M) Measurement of ATP synthesis
rates in cardiac mitochondria isolated from failing hearts of the indicated groups. ATP synthesis was driven by complex I (pyruvate/malate, 5 mM) and complex II
(succinate 5 mM). The specificity of the measurements was verified using inhibitors (0.5 μM) of respiratory complex, as indicated (n = 3 per group, triplicate
measurements per sample). All data are shown as mean ± SEM, *P < 0.05 vs. WT; #P < 0.05 vs. RyR2-S2808D, ANOVA, Tukey–Kramer post hoc test.
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Fig. 4. Cardiac ablation of IP3R2 does not rescue mitochondrial abnormalities observed in failing hearts. (A–D) Representative transmission electron
micrographs of cardiac mitochondria in SHAM conditions (A and B) and post myocardial infarction (C and D) from IP3R2fl/fl (A and C ) and IP3R2CVKO
mice (B and D), n = 5 per group. (Magnification: A–D, 15,000×; Insets, 50,000×.) (Scale bars: 500 nm.) (E–J) Morphometric analysis of mitochondrial
ultrastructure. Mitochondrial size (E ) and cristae density (F ). Quantification of mitochondrial number per image (G) and percentage of abnormal
mitochondria per image at 15,000× (H). Evaluation of aspect ratio (I) and format form (J) (see SI Materials and Methods for details). (K ) Mitochondrial
DNA (mtDNA)/nuclear DNA (nDNA) copy number assessed in left ventricular tissue. (L) Assessment of ATP content in left ventricle (n = 6 per group)
and (M ) measurement of ATP synthesis rates in isolated mitochondria in sham conditions and 4 wk after coronary artery ligation, as described in Fig.
3M. All data are shown as mean ± SEM, *P < 0.05 vs. SHAM; two-tailed t test. Numbers in the bars indicate the number of mitochondria analyzed.
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RyR2-S2808A mice harboring nonleaky RyR2 channels exhibi-
ted reduced depletion of calstabin2 from the RyR2 complex in
HF (Fig. 2 A and F), and significantly less RyR2 oxidation and
nitrosylation (Fig. 2 A–C) and reduced post-MI HF progression
(Fig. 2G and Table S1).
Taken together, our experimental findings demonstrate that
SR Ca2+ leak via RyR2, but not IP3R2, channels plays a crucial
role in the pathophysiology of mitochondrial Ca2+ overload and
dysfunction in HF. Our data suggest a feedback loop between SR
and mitochondria in HF in which SR Ca2+ leak triggers mito-
chondrial dysfunction and increases ROS production, which in
turn can further oxidize RyR2 and enhance intracellular Ca2+
leak, contributing to impaired cardiac function post-MI.
Materials and Methods
The targeted deletion of IP3R2 in ventricular cardiomyocytes was obtained by
flanking exon 3 of IP3R2with loxP sites (Fig. S2). Mice harboring the IP3R2flox/flox
allele were bred with MHC-Cre transgenic mice to obtain a cardiac ventricular-
specific ablation of IP3R2. A detailed description of materials and methods for
in vivo experiments (31–35), isolation of adult cardiomyocytes (34, 36), isolation
of mitochondria (37), assessment of mitochondrial dynamics, Ca2+ content,
and membrane potential (34, 37), real-time RT-qPCR (38, 39), immunoprecipi-
tation/immunoblot, and electron microscopy (40) can be found in SI Materials
and Methods.
Ethical Approval. All studies were performed according to protocols approved
by the Institutional Animal Care and Use Committee (IACUC) of Columbia
University.
Statistics. All results are presented as mean ± SEM. Statistical analysis was
performed using an unpaired two-tailed t test (for two groups) and one-
way ANOVA with Tukey–Kramer post hoc test (for groups of three or
more) unless otherwise indicated. P values of less than 0.05 were considered
significant.
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SI Materials and Methods
Targeted Deletion of IP3R2 in Ventricular Cardiomyocytes. Exon 3 of
IP3R2 was targeted by flanking it with loxP sites (Fig. S2). Mice
harboring the IP3R2flox/flox allele (IP3R2fl/fl) were bred with
MHC-Cre transgenic mice to obtain a cardiac ventricular-spe-
cific ablation of IP3R2 (IP3R2CVKO). Genotypes were verified
by PCR (Fig. S2 and Table S2). Generation of mCAT, RyR2-
S2808D, and RyR2-S2808A mice has been described (1, 31, 33).
All mice were backcrossed into the C57BL/6 background for >10
generations. All animal studies were performed according to
protocols approved by the Institutional Animal Care and Use
Committee (IACUC) and according to NIH guidelines. All
in vivo and in vitro experiments were conducted on male mice by
operators who were blinded to the genotypes of the animals. No
samples, mice, or data points were excluded from the reported
analyses.
In Vivo Experiments. Transthoracic 2D echocardiography was
performed using a 12-MHz probe (VeVo; Visualsonics). M-mode
interrogation was performed in the parasternal short-axis view.
Left ventricular (LV) end-diastolic and end-systolic dimensions
and septal and posterior wall thicknesses were determined and
used to calculate fractional shortening and ejection fractions (32).
After baseline echocardiography, permanent occlusion of the
proximal left anterior descending (LAD) coronary artery was
performed in 5-mo-old mice. A small (1.5-cm) left thoracotomy
was performed via the fourth intercostal space, and the lungs were
retracted to expose the heart. After opening the pericardium, the
LAD coronary artery was located and ligated with 8-0 silk suture
near its origin between the pulmonary outflow tract and the edge
of the left atrium, 2 mm lower than the tip of the left auricle. The
ligation was deemed successful when the anterior wall of the LV
turned pale. Animals were kept on a heating pad until they re-
covered. The group of mice undergoing sham ligation had a
similar surgical procedure without tightening the suture around
the artery. Echocardiography was repeated at 1, 2, and 4 wk post-
MI. Serum concentration of troponin I was measured 1 d after
coronary artery ligation using a commercially available immu-
noassay kit to indirectly estimate myocardial infarct size. Infarct
area was also assessed in a distinct group of animals using 2-3-5-
triphenyltetrazolium chloride and expressed as percentage of
total LV area. Blood pressure and cardiac contractility were
measured as described (32).
Isolation of Adult Cardiomyocytes and Measurement of Ca2+ and
Mitochondrial Membrane Potential. The hearts were excised and
washed in Ca2+-free Tyrode solution, followed by retrograde
perfusion with buffer containing collagenase II (Worthington
Biochemical Corporation) at 37 °C for 10 min. The LV was
subsequently dissociated into single myocytes, and extracellular
Ca2+ concentration was progressively increased to reach a final
concentration of 1.8 mM. Cardiomyocytes were plated on glass
coverslips coated with laminin (Thermo Fisher Scientific). To
determine intracellular [Ca2+], cardiomyocytes were loaded with
5 μM Fluo-4 acetoxymethyl (AM) ester (Thermo Fisher Scien-
tific) for 20 min and washed three times with dye-free Tyrode
solution. Ca2+ sparks were recorded using a Zeiss LSM 5 Live
confocal microscope in line scan mode. The fluorophore was
excited with an argon laser at 488 nm, and emission was recorded
at 505–530 nm. Ca2+ sparks were quantified using a software
algorithm (IDL; ITT Visual Information Solutions) and calcu-
lated as sparks/100 μm/s (34–36). Dynamic mitochondrial Ca2+
was evaluated in enzymatically isolated cardiomyocytes in-
cubated with Rhod2-AM (2 μm; Thermo Fisher Scientific) for
1 h at 37 °C and then washed for deesterification. After loading,
the cells were placed on the stage of a Zeiss LSM 5 Live confocal
microscope (63× oil immersion lens) where Rhod2 fluorescence
signals were recorded by excitation at 561 nm and measurement
of the emitted light at 588 nm. Cardiomyocytes were stimulated
by pacing (3 Hz) or pharmacologically triggering Ca2+ leak via
RyR2 using FK506 (5 μM).
To assess mitochondrial ROS levels, isolated cardiomyocytes
were incubated for 20 min with the mitochondria-targeted
fluorescent indicator of superoxide production MitoSOX Red
(5 μM; Thermo Fisher Scientific) and washed. Using a confocal
laser-scanning microscope (Zeiss LSM 5 Live, 40× oil immersion
lens), MitoSOX Red fluorescence was excited at 488 nm, and the
emitted signal was filtered through a band pass filter (540–625 nm).
The scanned parameters were fixed for all scans. For each group,
fluorescence intensities of >100 cells randomly selected from sev-
eral different dishes were examined.
To measure mitochondrial membrane potential (Δψm), car-
diomyocytes were incubated with the fluorescent indicator tetra-
methylrhodamine ethyl ester (TMRE; 30 nM; Thermo Fisher
Scientific) for 20 min. TMRE fluorescence was excited at 532
nm, and the emitted signal was collected through a band pass
filter (540–625 nm, Zeiss LSM 5 Live, 40× oil immersion lens).
To minimize the impact of subcellular variability on Δψm,
TMRE fluorescence was measured in five different areas in each
cell. At the end of each experiment, cells were exposed to the
mitochondrial uncoupler carbonylcyanide-p-trifluoro-methoxy-
phenyl-hydrazone (FCCP, 300 nM). Images were obtained every
5 min, and fluorescence signals were normalized to the fluores-
cence measured at the start of the experiment.
Isolation of Cardiac Mitochondria. Murine cardiac mitochondria
were isolated using previous established procedures (11, 13, 37).
In brief, mice were euthanized, and the heart was excised. The LV
was minced on ice, resuspended, and homogenized in 1.5 mL of
buffer (10 mM Tris, 250 mM sucrose, 1× protease inhibitor
mixture, pH 7.4) supplemented with 1 mM EDTA. Homoge-
nates were centrifuged at 1,000 × g for 5 min at 4 °C (pellet
discarded and supernatant recentrifuged at 500 × g). The su-
pernatant was centrifuged at 10,000 × g for 15 min to pellet the
mitochondria. The pellet was then resuspended in the homoge-
nization buffer (without EDTA) and used for experiments within
1 h. All steps were performed at 4 °C. ATP synthesis rates in
isolated cardiac mitochondria were determined using a bio-
luminescence kit (Sigma-Aldrich), according to the manufac-
turer’s instructions. Briefly, 10 μg of cardiac mitochondria were
dissolved in 50 μL of buffer (10 mM Hepes, 125 mM KCl, 5 mM
MgCl2, 2 mM K2HPO4, pH 7.42) to determine complex I (5 mM
pyruvate/malate) or complex II (5 mM succinate) driven ATP
synthesis. To determine the rates of nonmitochondrial ATP
production, measurements with substrates were repeated in the
presence (0.5 μM) of inhibitors of respiratory complex: rotenone
(complex I), antimycin (complex III), and oligomycin (complex
IV). To avoid the reverse electron transfer effect, succinate-
driven ATP synthesis was assessed in the presence of rotenone
(0.5 μM). ATP content in the LV was determined as described
(37). The endogenous mitochondrial Ca2+ content was mea-
sured in cardiac mitochondria isolated as reported above, ex-
cept that all buffers were EGTA/EDTA-free to avoid chelating
Ca2+. Isolated mitochondrial pellets were repeatedly washed
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in buffers, resuspended in 0.6 M HCl, and sonicated (2 × 10 s
at 40% of maximal power output). Absolute Ca2+ content
(expressed as nmoles/mg protein) was determined using the
o-cresolphthalein complexone assay (Cayman Chemical), according
to the manufacturer’s instructions.
Real-Time Quantitative Reverse Transcription PCR. Total RNA was
isolated using TRIzol reagent (Thermo Fisher Scientific) in
combination with the RNeasy Mini kit (Qiagen) followed by
DNase treatment (38, 39), and cDNA was synthesized by means of
a Thermo-Script RT-PCR System (Thermo Fisher Scientific), fol-
lowing the manufacturer’s instructions. After reverse transcription,
real-time quantitative PCR was performed in triplicate using the
SYBR Green RT-PCR master mix kit and quantified by built-in
SYBR Green Analysis (Thermo Fisher Scientific) (39, 40). To
determine mitochondrial and nuclear DNA copy number (mtDNA
and nDNA, respectively), a quantitative RT-qPCR was performed
on 30 ng of total left ventricular DNA in each qPCR reaction using
primer pairs for mitochondrial and genomic loci. Two different
primer pairs were used to quantify and confirm relative mito-
chondrial (mt)/nuclear (n) DNA ratio: 12S and 16S for mtDNA,
H19 and 18S for nDNA. Samples were measured in triplicate, and
results were confirmed by at least three independent experiments.
All of the primer sequences (Sigma-Aldrich) for gene analysis are
listed in Table S2.
Immunoprecipitation/Immunoblot Analysis.Left ventricular samples
were incubated with specific antibodies and protein A Sepharose
beads (Amersham Pharmacia Biotech Inc.) at 4 °C for 2.5 h, and
the beads were then washed. Immunoprecipitates were size-
fractionated on SDS/PAGE gels (6% for RyR2 and IP3R2, 15%
for calstabin2) and transferred onto nitrocellulose membranes
for 2 h at 200 mA. To determine channel oxidation, the carbonyl
groups in the protein side chains in the immunoprecipitated ma-
terial were derivatized to 2,4-dinitrophenylhydrazone (2,4 DNPH) by
reaction with 2,4-dinitrophenylhydrazine. The 2,4 DNPH signal was
determined using a specific antibody, according to the manufac-
turer’s instructions (Millipore). Anti-S-nitrosocysteine (anti-CysNO)
antibody was purchased from Sigma-Aldrich. All immunoblots were
developed with the Odyssey system (LI-COR Biosciences), using
infrared-labeled anti-mouse and anti-rabbit IgG (1:10,000 dilution)
secondary antibodies (40). The intensity of the bands was quantified
by using the LI-COR Image Studio Software (LI-COR Biosciences).
Transmission Electron Microscopy.Cardiac left ventricles were fixed
in 2.5% glutaraldehyde in 0.1 M Sørensen’s buffer and postfixed
in 1% OsO4. After dehydration, samples were embedded in Lx-
112 (Ladd Research Industries). After cutting (ultramicrotome
MT-7000), 60-nm sections were stained with uranyl acetate and
lead citrate and visualized (JEM-1200 EXII; JEOL). Eight to ten
randomly taken sections for each animal were examined for
morphological analyses, performed using Fiji software. Mito-
chondrial aspect ratio (major axis/minor axis) and form factor
(perimeter2/4π × area) were also measured. To estimate mito-
chondrial size and cristae density, a computerized point grid was
digitally layered over the micrographic images. The densities of
dots on the point grid were quantified as previously described
(40). All of the analyses were performed in a blinded fashion.
Fig. S1. Mitochondrial Ca2+ dynamics in isolated cardiomyocytes following pharmacologically triggered intracellular Ca2+ leak via RyR2. (A and B) Mito-
chondrial Ca2+ in response to FK506 (5 μM, arrow) was evaluated in cardiomyocytes (n = 20–35) enzymatically isolated from at least seven mice per group in
SHAM (A) and HF (B) conditions. Data are shown as mean ± SEM; *P < 0.05 vs. WT; #P < 0.05 vs. RyR2-S2808D; ANOVA repeated measures.
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Fig. S4. Assessment of mitochondrial morphological dynamism in HF. (A) Aspect ratio and (B) form factor were measured as described in SI Materials
and Methods in cardiac mitochondria from 6-mo-old WT, RyR2-S2808A, RyR2-S2808D, mCAT, and mCAT × RyR2-S2808D mice, 4 wk after myocardial infarction;
n ≥ 5 per group; see also Fig. 3 A–E. All data are shown as mean ± SEM; numbers in the bars indicate the number of mitochondria analyzed.
Fig. S5. Generation of cardiac specific ablation of IP3R2. (A) Schematic illustration of the generation of the IP3R2 floxed mouse (Top) and representative PCR
for the genotype detection of WT, IP3R2fl/fl, and IP3R2KO mice. (B) Determination of IP3R2 mRNA levels by real time quantitative reverse transcription PCR (RT-
qPCR) analysis of total RNA from isolated cardiomyocytes, using actin as internal standard; each bar represents mean ± SEM of four independent experiments,
in each of which reactions were performed in triplicate using the pooled total RNAs from five mice per group. (C) IP3R2 from isolated ventricular car-
diomyocytes was immunoprecipitated and immunoblotted. 2,4 DNPH, 2,4-dinitrophenylhydrazone. (D and E) Quantification of data shown in C. Data shown
represent means ± SEM from triplicate experiments. *P < 0.05 vs. IP3R2fl/fl, two-tailed t test. (F and G) Levels of IP3R isoforms after cardiac-specific ablation of
IP3R2. Determination of IP3R1 (F) and IP3R3 (G) mRNA levels by RT-qPCR analysis of total RNA from isolated cardiomyocytes, using actin as internal standard;
each bar represents mean ± SEM of four independent experiments, in each of which reactions were performed in triplicate using the pooled total RNAs from
five mice/group.
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Fig. S6. Effects of cardiac ablation of IP3R2 on Ca2+ spark frequency, SR Ca2+ load, mitochondrial Ca2+ content, and ROS production. (A) Average Ca2+ spark
frequency, (B) SR Ca2+ load, and (C) mitochondrial Ca2+ in ventricular cardiomyocytes (n = 20∼22 cells) isolated from at least six mice per group in SHAM and HF
conditions. Data are shown as mean ± SEM. (D) Evaluation of mitochondrial ROS generation in ventricular cardiomyocytes using the mitochondria-targeted
fluorescent indicator of superoxide production MitoSOX Red. n > 100 ventricular myocytes from at least four mice in each group. AU, arbitrary units. Data are
shown as mean ± SEM, *P < 0.05 vs. WT; one-way ANOVA, Tukey–Kramer post hoc test.
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Fig. S7. Effects of cardiac ablation of IP3R2 on mitochondrial Ca2+ dynamics and HF progression after myocoardial infarction. (A) Mitochondrial Ca2+ in
response to 3 Hz stimulation was evaluated in cardiomyocytes (n = 25–30) enzymatically isolated from at least seven mice per group in SHAM (solid lines) and
HF (dotted lines) conditions. (B) The mitochondrial Ca2+ peak. Data are shown as means ± SEM, *P < 0.05 vs. SHAM, two-tailed t test. (C) Progressive cardiac
dysfunction after left anterior coronary artery ligation assessed by serial ultrasound in IP3R2fl/fl and IP3R2CVKO. LVEF, left ventricular ejection fraction; n = 16–18
per group. See also Table S1.
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Fig. S8. Xanthine oxidase expression is increased in failing hearts, and in vivo genetic enhancement of mitochondrial antioxidant activity does not prevent
such increase. (A) Representative immunoblots showing xanthine oxidase levels in cardiomyocytes enzymatically isolated from at least seven mice per group in
SHAM and HF conditions. GAPDH was used as loading control. (B) Densitometry quantification from triplicate experiments; data are shown as mean ± SEM,
*P < 0.05 vs. SHAM.
Table S1. Characteristics of 6-mo-old SHAM and HF (post-MI) mice
Characteristic WT RyR2-S2808A RyR2-S2808D mCAT mCATx RyR2-S2808D IP3R2fl/fl IP3R2CVKO
SHAM
BW, g 25.4 ± 0.8 26.1 ± 1.1 25.1 ± 1.1 25.8 ± 1.1 25.2 ± 0.9 26.2 ± 0.9 26.5 ± 1.1
HR, bpm 506 ± 46 496 ± 52 492 ± 48 490 ± 54 498 ± 42 502 ± 46 482 ± 56
HW/BW, mg/g 4.8 ± 0.5 4.9 ± 0.4 5.2 ± 0.5 4.7 ± 0.4 5.1 ± 0.5 4.9 ± 0.5 4.8 ± 0.3
LW/BW, mg/g 5.4 ± 0.4 5.3 ± 0.3 5.8 ± 0.4 5.3 ± 0.4 5.5 ± 0.4 5.3 ± 0.4 5.4 ± 0.5
EF, % 78.08 ± 1.1# 78.26 ± 1.2# 60.26 ± 0.9* 78.68 ± 1.1# 67.18 ± 1.1*,# 78.32 ± 1.2# 77.14 ± 1.1#
FS, % 51.11 ± 1.1# 50.92 ± 1.1# 31.76 ± 0.8* 51.18 ± 0.9# 35.94 ± 0.7*,# 51.66 ± 1.1# 50.78 ± 0.9#
DBP, mmHg 80.12 ± 2.4 81.1 ± 2.7 80.11 ± 2.1 80.22 ± 2.1 79.8 ± 2.2 82.34 ± 2.7 81.9 ± 2.9
dP/dtmax, mmHg/s 7685 ± 522
# 7849 ± 535# 6702 ± 392* 7689 ± 593# 7115 ± 514*,# 7724 ± 536# 7692 ± 544#
dP/dtmin, mmHg/s 6125 ± 415
# 6214 ± 488# 5055 ± 495* 6152 ± 501# 5568 ± 487*,# 6234 ± 472# 6208 ± 465#
HF
BW, g 25.7 ± 1.1 26.2 ± 1.1 25.3 ± 1.1 25.6 ± 1.2 25.5 ± 0.9 26.1 ± 1.2 26.7 ± 1.3
HR, bpm 488 ± 46 478 ± 35 484 ± 46 475 ± 38 482 ± 48 488 ± 58 462 ± 44
HW/BW, mg/g 8.1 ± 0.6 7.8 ± 0.5# 9.2 ± 0.6 7.6 ± 0.4# 8.4 ± 0.5 8.2 ± 0.7# 7.9 ± 0.6#
LW/BW, mg/g 7.3 ± 0.4# 6.5 ± 0.4*,# 8.6 ± 0.5* 6.4 ± 0.4*,# 7.6 ± 0.5 7.2 ± 0.6# 6.7 ± 0.5#
EF, % 37.15 ± 0.3# 45.15 ± 0.6*,# 31.06 ± 0.4* 42.11 ± 0.4*,# 35.02 ± 0.3*,# 36.91 ± 0.5# 40.51 ± 0.7#
FS, % 18.64 ± 0.3# 21.76 ± 0.4*,# 15.12 ± 0.3* 20.14 ± 0.4# 17.64 ± 0.3*,# 17.81 ± 0.4# 19.96 ± 0.6#
DBP, mmHg 81.62 ± 2.6 83.4 ± 2.9 80.61 ± 2.5 81.45 ± 2.3 81.5 ± 2.1 80.96 ± 3.1 82.48 ± 2.8
dP/dtmax, mmHg/s 5881 ± 402
# 6752 ± 466*,# 3946 ± 384* 6728 ± 442*,# 5520 ± 433# 5872 ± 464# 6432 ± 482#
dP/dtmin, mmHg/s 5006 ± 398
# 5834 ± 422*,# 3348 ± 362* 5866 ± 408*,# 4718 ± 416# 5086 ± 412# 5766 ± 474#
Serum TnI, ng/mL 62.4 ± 12.5 61.8 ± 10.2 61.5 ± 11.8 61.2 ± 10.5 62.4 ± 12.5 60.6 ± 10.8 61.1 ± 12.8
Infarct size, % of LV 43.6 ± 4.4 42.2 ± 4.3 39.7 ± 3.9 42.8 ± 4.6 41.1 ± 4.3 43.1 ± 4.5 43.8 ± 4.1
BW, body weight; DBP, diastolic blood pressure; dP/dtmax, maximum derivative of change in pressure rise over time; dP/dtmin, maximum derivative of change
in pressure fall over time; EF, ejection fraction; FS, fractional shortening; HR, heart rate; HW, heart weight; LW, lung weight; TnI, Troponin I measured 1 d after
coronary artery ligation; n = 16–20 mice per group for echo, BW, HW/BW, LW/BW, and TnI measurements, n = 6–7 mice per group for hemodynamic
measurements; measurements reported in the second section of the table (HF) were obtained 4 wk after myocardial infarction (MI); infarct size is expressed
as % of left ventricle (LV) in distinct groups of mice (5–6 mice per group, 5-mo-old), 2 d post-MI. Parameters that are significantly different (P < 0.05, two-tailed
t test) compared with SHAM conditions are reported in bold. *P < 0.05 vs. WT, #P < 0.05 vs. RyR2-2808D, ANOVA, Tukey–Kramer post hoc test.
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Table S2. Primer sequences
Gene Forward 5′–3′ Reverse 5′–3′ Product size, bp
IP3R1 TGGTCCAGCACTTTGTTCAC TCTGCCTTGACAATCGTCTG 85
IP3R2 AGACTCTCAGCTCGCTCTGG GGCCACGACATCCTGTAACT 99
IP3R3 ACATCCTGGCTGAAGACACC AAAGGTCTCCACCTCCGTCT 92
Actin CTCTTCCAGCCTTCCTTCCT AGCACTGTGTTGGCGTACAG 116
H19 GTACCCACCTGTCGTCC GTCCACGAGACCAATGACTG 207
18S CGCGGTTCTATTTTGTTGGT AGTCGGCATCGTTTATGGTC 219
mt12S ACCGCGGTCATACGATTAAC CCCAGTTTGGGTCTTAGCTG 178
mt16S CCTTGTTCCCAGAGGTTCAA ATGCCGTATGGACCAACAAT 169
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